GlassScriptPhysician profile
Richard Michael Jacoby
NPI 1053353029
$2,262.30
in general payments reported to CMS, 2019-2025
22 companies · $66.69 in 2025
The $66.69 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $25.52 · 2021: $299 · 2022: $492 · 2023: $170 · 2024: $34.82 · 2025: $66.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $834.57 | 2019-2023 | |
| Edwards Lifesciences Corporation | $274.80 | 2019 | |
| Astellas Pharma US INC | $199.94 | 2022 | |
| Philips North America LLC | $155.46 | 2021-2022 | |
| Medtronic, INC. | $132.57 | 2022-2023 | Telescope |
| Astrazeneca Pharmaceuticals LP | $127.43 | 2021 | |
| Abbott Laboratories | $113.79 | 2019-2024 | Navitor |
| Janssen Pharmaceuticals, INC | $70.65 | 2019-2021 | |
| Abiomed | $47.15 | 2021-2025 | |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Cardiovascular Systems INC. | $38.51 | 2022 | |
| Biotronik INC. | $32.17 | 2021 | |
| Shockwave Medical, INC | $23.27 | 2022 | |
| Chiesi USA, INC. | $23.10 | 2022 | |
| Medtronic Vascular, INC. | $21.68 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20.23 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.38 | 2021 | |
| Osiris Therapeutics INC. | $18.80 | 2019 | |
| Amgen INC. | $17.33 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.43 | 2021 | |
| Terumo Medical Corporation | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Jacoby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.